Detalles de la búsqueda
1.
A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
Invest New Drugs
; 31(3): 599-604, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623066
2.
Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients.
Jpn J Clin Oncol
; 40(1): 54-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19837690
3.
Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer.
Clin Cancer Res
; 18(22): 6219-26, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22843788
4.
A novel mass spectrometry-based assay for diagnosis of EML4-ALK-positive non-small cell lung cancer.
J Thorac Oncol
; 7(5): 913-8, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22722791
5.
HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.
Cancer Discov
; 2(10): 922-33, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22956644
6.
Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.
Clin Cancer Res
; 17(8): 2140-8, 2011 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21415216
7.
MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations.
J Thorac Oncol
; 6(10): 1624-31, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21716144
8.
Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations.
Cancer Res
; 70(24): 10402-10, 2010 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21159653
9.
Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor.
Mol Cancer Ther
; 9(6): 1647-56, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20530710
10.
Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplification.
Mol Cancer Ther
; 9(5): 1198-207, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20424000
11.
Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition.
Mol Cancer Ther
; 9(5): 1188-97, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20406949
12.
Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
Cancer Res
; 69(16): 6515-21, 2009 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19638574
13.
Pharmacokinetic analysis of carboplatin and etoposide in a small cell lung cancer patient undergoing hemodialysis.
J Thorac Oncol
; 3(9): 1073-5, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18758316
14.
Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein production.
J Thorac Oncol
; 3(2): 187-9, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18303442
Resultados
1 -
14
de 14
1
Próxima >
>>